Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Imaging Adrenal Acans

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07205562Not Yet RecruitingPrimary

Serum Electrolyte Abnormalities as Prognostic Factor for Outcome in Critically Ill Children

NCT00591643Phase 1Completed

Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)

Showing all 2 trials

Research Network

Common Treatments

  • Imaging Adrenal Acans1
  • Np591

Active Sponsors

  • Assiut University1
  • Memorial Sloan Kettering Cancer Center1

Top Investigators

Related Conditions

  • Children1
  • Abnormal Hormonal Secretions1
  • Prognostic Factors1
  • Adrenal Tumors1
  • Adrenal Malignancies1

Activity Timeline